Corporate influence over planning and presentation of clinical trials: beauty and the beast. [electronic resource]
- Expert review of cardiovascular therapy Jan 2010
- 7-9 p. digital
Publication Type: Editorial; Research Support, Non-U.S. Gov't
1744-8344
10.1586/erc.09.160 doi
Cardiovascular Agents--economics Cardiovascular Diseases--drug therapy Drug Industry--economics Humans Practice Guidelines as Topic Randomized Controlled Trials as Topic--ethics